SCHEMBL397286

SCHEMBL397286

CC/C=C/CCOC(=O)c1ccccc1O

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.61
ALDH1A1 P00352 5/20 0.51
TSHR P16473 7/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
LMNA P02545 3/20 0.49
TP53 P04637 1/20 0.47
CYP3A4 P08684 1/20 0.47
MAPK1 P28482 1/20 0.47
HTT P42858 1/20 0.47
KMT2A Q03164 1/20 0.47
SIRT5 Q9NXA8 1/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
HSD17B10 Q99714 2/20 0.43
ADRB2 P07550 1/20 0.43
ADRB1 P08588 1/20 0.43
ADRB3 P13945 1/20 0.43
HPGD P15428 1/20 0.42
ALOX15 P16050 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL111558 1.00 TDP1 (0.61) TDP1ALDH1A1TSHRL3MBTL1LMNA
SCHEMBL111557 1.00 TDP1 (0.61) TDP1ALDH1A1TSHRL3MBTL1LMNA
SCHEMBL30367352 1.00 TDP1 (0.61) TDP1ALDH1A1TSHRL3MBTL1LMNA
Salicylic Acid SCHEMBL1868664 0.94 TDP1 (0.55) TDP1ALDH1A1TSHRL3MBTL1LMNA
2-Hydroxybenzoic Acid Hexyl Ester SCHEMBL29088839 0.91 ALDH1A1 (0.63) TDP1ALDH1A1TSHRL3MBTL1LMNA
Benzyl Salicylate SCHEMBL28291087 0.91 TDP1 (0.68) TDP1ALDH1A1TSHRL3MBTL1LMNA
SCHEMBL1868662 0.91 ALDH1A1 (0.52) TDP1ALDH1A1TSHRL3MBTL1LMNA
2-Hydroxybenzoic Acid Hexyl Ester SCHEMBL29088840 0.91 ALDH1A1 (0.63) TDP1ALDH1A1TSHRL3MBTL1LMNA
SCHEMBL31325421 0.89 TDP1 (0.63) TDP1ALDH1A1TSHRL3MBTL1LMNA
SCHEMBL29141613 0.87 TDP1 (0.58) TDP1ALDH1A1TSHRL3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 340 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4419070-A1 MALODOR-COUNTERACTING COMPOUNDS, COMPOSITIONS, AND USES THEREOF International Flavors & Fragrances Inc. (US) 2024-08-28 EP claimed
WO-2023199324-A1 MIXTURE OF 3-HEXENYL ESTER ISOMERS AND USES THEREOF AGAN AROMA & FINE CHEMICALS LTD. (IL) 2023-10-19 WO claimed
WO-2023069548-A1 MALODOR-COUNTERACTING COMPOUNDS, COMPOSITIONS, AND USES THEREOF INTERNATIONAL FLAVORS AND FRAGRANCES INC. (US) 2023-04-27 WO claimed
US-11603506-B2 Product comprising a plastic container and a substance composition SYMRISE AG (DE) 2023-03-14 US claimed
US-20190225396-A1 PRODUCT COMPRISING A PLASTIC CONTAINER AND A SUBSTANCE COMPOSITION SYMRISE AG (DE) 2019-07-25 US claimed
EP-3507352-A1 PRODUCT COMPRISING A PLASTIC CONTAINER AND A SUBSTANCE COMPOSITION Symrise AG (DE) 2019-07-10 EP claimed
EP-3423028-A1 METHOD FOR THE PRODUCTION OF SCENT CAPSULES WITH IMPROVED SURFACTANT STABLITY Symrise AG (DE) 2019-01-09 EP claimed
WO-2018041354-A1 PRODUCT COMPRISING A PLASTIC CONTAINER AND A SUBSTANCE COMPOSITION SYMRISE AG (DE) 2018-03-08 WO claimed
EP-2204156-B1 Fragrance composition for core shell microcapsules TAKASAGO PERFUMERY CO LTD (JP) 2017-02-01 EP claimed
US-9119973-B2 Fragrance composition for core shell microcapsules TAKASAGO INTERNATIONAL CORPORATION (JP) 2015-09-01 US claimed
EP-2204155-A1 Fragrance composition for core shell microcapsules Takasago International Corporation (JP) 2010-07-07 EP claimed
EP-2204156-A1 Fragrance composition for core shell microcapsules Takasago International Corporation (JP) 2010-07-07 EP claimed
US-20100168251-A1 FRAGRANCE COMPOSITION FOR CORE SHELL MICROCAPSULES TAKASAGO INTERNATIONAL CORPORATION (JP) 2010-07-01 US claimed
US-20260047994-A1 AN ACTIVE COMPOSITION COMPRISING RETINOL SYMRISE AG (DE) 2026-02-19 US disclosed
US-12508218-B2 Coating compositions COTY INC. (US) 2025-12-30 US disclosed
EP-3103523-B1 ABSORBENT ARTICLE COMPRISING FRAGRANCE COMPOSITION PROCTER & GAMBLE (US) 2025-10-29 EP disclosed
WO-2002006437-A1 CLEANING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2002-01-24 WO disclosed
EP-0977549-A1 PERFUMES HAVING ODOR LONGEVITY BENEFITS THE PROCTER & GAMBLE COMPANY (US) 2000-02-09 EP disclosed
WO-1998047478-A1 PERFUMES HAVING ODOR LONGEVITY BENEFITS THE PROCTER & GAMBLE COMPANY (US) 1998-10-29 WO disclosed
US-4624802-A Salicylic acid esters of carbocyclic alcohols as perfumes or scenting agents, perfumery compositions and salicylic acid esters HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1986-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260047994-A1 AN ACTIVE COMPOSITION COMPRISING RETINOL RBP4, LRAT, RARB TDP1 2532/4885ALDH1A1 156/4885TSHR 1692/4885
US-20100168251-A1 FRAGRANCE COMPOSITION FOR CORE SHELL MICROCAPSULES C5, CACNG5, COPG1 TDP1 4551/4885ALDH1A1 1718/4885TSHR 4659/4885
US-12508218-B2 Coating compositions TAS2R40, TAS2R20, TAS2R10 TDP1 3611/4885ALDH1A1 3806/4885TSHR 3449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.